May 23, 2012 — The US Food and Drug Administration (FDA) today issued an advisory warning healthcare providers to visually inspect Hospira Carpuject prefilled cartridges for overfill. About 46 million ...
An investigation into user complaints of overfilled Carpuject syringes led Hospira ($HSP) to realize manufacturing problems with overfills were far more extensive ...
UNDATED - Hospira, Inc., a Pfizer company, is voluntarily recalling lots 72680LL and 76510LL of Naloxone Hydrochloride Injection, USP, 0.4 mg/mL, 1 mL in 2.5 mL, Carpuject Single-use cartridge syringe ...
Abbott Laboratories signed a definitive agreement to acquire parenteral products businesses from Sanofi Pharmaceuticals Inc. for $200 million. Abbott said it will receive worldwide rights to prefilled ...
April 19, 2012 — Hospira Inc has initiated a voluntary recall of morphine sulfate injections because of a customer report of 2 Carpuject syringes containing more than the 1 mL labeled fill volume. The ...
Hospira announced a nationwide voluntary recall of one lot of Morphine Sulfate injection, 4mg/mL, due to a customer report of two Carpujects syringes containing more than the 1mL labeled fill volume.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback